ERIC YUKUMOTO: Open Payments
NPI 1841431400 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,596 in 103 payments from 16 companies in 2025. Trend: 2023 $17,415 · 2024 $7,032 · 2025 $8,596
Consulting: $5,160Food & beverage: $2,783Speaker / faculty: $506Education: $148
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $5,690 |
| GENZYME CORPORATION | 20 | $645 |
| Galderma Laboratories, L.P. | 12 | $463 |
| Arcutis Biotherapeutics, Inc. | 16 | $293 |
| Organon LLC | 9 | $231 |
| UCB, Inc. | 3 | $204 |
| Novartis Pharmaceuticals Corporation | 9 | $184 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $148 |
| Blueprint Medicines Corporation | 2 | $146 |
| LEO Pharma Inc. | 8 | $136 |
Products named: CIBINQO, DUPIXENT, NEMLUVIO, Zoryve, Bimzelx, VTAMA, AKLIEF, Sotyktu.
Industry payments across HI — which companies pay providers there.
